Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Jul 16;10:12080. doi: 10.1038/s41598-020-69088-7

Author Correction: Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis

Motoyasu Kato 1,, Shinichi Sasaki 1,2, Takahiro Nakamura 1, Kana Kurokawa 1, Tomoko Yamada 1, Yusuke Ochi 1, Hiroaki Ihara 1, Fumiyuki Takahashi 1, Kazuhisa Takahashi 1
PMCID: PMC7363798  PMID: 32669649

Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-48593-4, published online 19 August 2019

This Article contained errors in Tables 1, 3 and 4 due to incorrectly written code.

In Table 1, the totals reported for PS 0-1/2-4, mMRC 0-1/2-4 and GAP index 1-5/6-9 under the subheading “Present study n = 77”, are incorrect.

The correct totals should read 55/22, 52/25 and 46/31 respectively.

As a result, in the Results section under the subheading ‘Patients characteristics’,

“The median age was 71 (range: 46–88) years. There were 12 (15.6%) women, 11 (14.3%) non-smokers, and 24 (31.2%) patients with a poor PS (2–4). The mean BMI was 22.9 ± 0.72 kg/m2.”

should read:

“The median age was 71 (range: 46–88) years. There were 12 (15.6%) women, 11 (14.3%) non-smokers, and 22 (28.6%) patients with a poor PS (2–4). The mean BMI was 22.7 ± 3.95 kg/m2.”

In Table 3, the totals reported for BMI < 21.6 and BMI ≥ 21.6 are incorrect.

The correct totals should read 25, 12, 13 and 52, 40, 12 respectively.

In Table 4, the totals reported for PS 0-1/2-4, BMI < 21.6, BMI ≥ 21.6 and Nintedanib dose for 300 mg/day and 200 mg/day are incorrect.

The correct totals should read 55, 39, 16 and 22, 11, 11 and 25, 10, 15 and 52, 40, 12 and 51, 34, 17 and 26, 16, 10 respectively.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES